Archives: October 2016

A shift in medicine – why pharmaceutical companies are vying for the next blockbuster therapy – The Conversation – October 24, 2016

In recent years, there has been a shift in the focus of pharmaceutical companies, with the trend now focusing on discovering the next US$1billion “Blockbuster” medicine treatment for a rare disease state. In a new research piece published by online medical news site, The Conversation, researchers have identified that one of...

read more